Abbott’s second-quarter earnings showed a mixed bag with pandemic disruptions on the medical device side of the business, and sales of COVID-19 tests driving growth for the diagnostic side.
https://i1.wp.com/mtgelectronics.com/wp-content/uploads/2020/07/shutterstock_105421997.jpg?fit=1000%2C667&ssl=1 667 1000 admin https://mtgelectronics.com/wp-content/uploads/2021/03/MTG-logo-for-site-300x100-1.png admin2020-07-23 08:40:452021-03-03 08:55:55Abbott’s COVID-19 tests did the heavy lifting in Q2
- Top Fifty Authorized Distributors 2021May 10, 2021 - 8:21 am
- The Boeing Company 2021 Q1 Earnings Call Presentation May 10, 2021 - 8:18 am
- Raytheon nabs $318M contract for deploying airport screening equipment May 10, 2021 - 8:15 am
- Semiconductor Chip Shortage Update: Relief in Sight? May 10, 2021 - 8:12 am